Healthcare

India has come up as a reliable healthcare destination with steadily expanding coverage and improving expertise.

Last updated: May 11, 2022

India's healthcare market holds the potential to grow three times to cross US$372bn by 2022.

13%

CAGR in in-patient market over 2015-20.

Top 3

healthcare markets in terms of incremental growth by 2020.

100%

FDI allowed under automatic route for greenfield projects.

US$2.3bn

Government investment over the period 2017-18 to 2019-20.

Ayushman Bharat

aims to provide annual healthcare coverage of nearly US$7,000 per family, benefiting more than 500 million vulnerable people.

US$32bn

diagnostics market expected by 2022, based on a CAGR of 20.4% from US$5bn in 2012.

28%

annual growth in India's healthcare technology startup space, where AI, IoT and data analytics are put to use for innovation solutions.

Medical Tourism

The Indian medical tourism industry, currently valued at around US$3bn, is expected to touch US$8bn by 2022.

US$21bn

expected valuation of India’s wellness and traditional healthcare industry by 2020, from the current US$10bn valuation.

US$4bn

worth od diagnostics industry in India is with the share of the organized sector being almost 25% in this segment (15% in labs and 10% in radiology).

US$13bn

worth of primary care industry with the share of the organized sector being practically negligible.

National Health Policy

The primary aim of the policy is to inform, clarify, strengthen and prioritize the role of the Government in shaping health systems in all its dimensions.
Ayushman Bharat

The programme aims to provide annual healthcare coverage of nearly US$7,000 per families, benefiting more than 500 million vulnerable people.
Rashtriya Arogya Nidhi

The RAN was set up to provide financial assistance to patients, living below poverty line and those who are suffering from major life threatening diseases, to receive medical treatment at any of the super specialty hospitals/institutes or other Government hospitals.
National AYUSH Mission

The NAM is being implemented by Ministry of AYUSH with the objective of providing cost effective AYUSH services.
COVID-19 Research for Diagnostics, Vaccines and Therapeutics

A Research strategy has been evolved at the Department of Biotechnology (DBT) for immediate response and long-term preparedness to combat COVID-19 infection.

Rashtriya Arogya Nidhi

The RAN was set up to provide financial assistance to patients, living below poverty line and who are suffering from major life threatening diseases, to receive medical treatment at any of the super speciality Hospitals/Institutes or other Government hospitals.

Scheme for Development of Ayush Clusters

The industry, that has approximate annual turnover of US$ 1.61 bn is essentially dominated by micro, small and medium enterprises (MSMEs) which account for more than 80% of the enterprises that are located in identifiable geographical clusters.
Central Sector Scheme on Conservation, Development and Sustainable Management of Medicinal Plants

India is home to diverse range of medicinal plants which have been used for centuries by the local people to meet not only their own primary health care needs but also to address ailments of domesticated animals (Pashuayurveda) & crops.

Central Sector Scheme for Promotion of Information, Education, and Communication (IEC) in AYUSH

Though AYUSH systems of medicine are popular and progressively a large section of population uses these systems for health care, there is lack of awareness among the general public about remedies available in these systems.

lndia COVlD-19 Emergency Flesponse and Health system pneparedness package

With a proposed investment amount of US$ 2.4 bn, the Package is to be implemented in three stages.

The National Commission for Indian System of Medicine Bill, 2020

The Bill proposes the institution of a 29 member body called the National Commission for Indian System of Medicine (NCISM) which will serve as a regulatory body for the system at large.
The National Commission for Homoeopathy Bill, 2020

The Bill aims to facilitate adequate resources for homeopathy education and the subsequent state-wide institution of regulatory councils in the National Commission for Homoeopathy (NCH).

Cabinet approves the extension of the Scheme for Financial Support to Public Private Partnerships

The revamped Schemes would be applicable to the Social Infrastructure domain including Healthcare, Education and Water Treatment. 30% of the Total Project Cost is to be taken up by the Central Government.

Association of Healthcare Providers (India)

+91-11-23379651

Visit Website

The vison of the Association is to have a healthy India, encompassing society, community and common man at the grassroots.

Medical Technology Association of India

+91 124 4382629

Visit Website

MTaI is an association of research-based medical technology companies who have made remarkable investments by setting up a large number of R&D centres and manufacturing plants in India.

Indian Home & Personal Care Industry Association

+91-22-28741366

Visit Website

The Association represents the Home & Personal Care (HPC) industry and provides a platform for National & International networking and interaction with regulatory bodies.

Indian Medical Association

+91-11-23370009, +91-9999116375

Visit Website

Indian Medical Association is the only representative, national voluntary organisation of Doctors of Modern Scientific System of Medicine, which looks after the interest of doctors as well as the well being of the community at large..

Ministry of Health and Family Welfare

investment opportunities

  • Government of India is setting up multiple campuses of All India Institute of Medical Sciences (AIIMS).
  • India has come up as one of the leading destinations for high-end diagnostic services with strong investment.
  • Vast opportunities in setting up and expanding drug formulation R&D as well as testing activity.
  • Investment opportunities in building world-class hospitals, as well as training of human resources required.
  • Opportunities in medical tourism promotion, infrastructure and services drawing foreign visitors.
Useful Links:

key investors

India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive and capital establishments

American drugmaker Merck operates a manufacturing plant in India.

French drugmaker Sanofi operates a manufacturing plant in Goa.

UK's GlaxoSmithKline operates R&D and manufacturing in India.

Singapore's 4CE Ventures has invested in Indian health tech startups.

ENABLING ENVIRONMENT

India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive, and capital establishments

Gene-editing and biotechnology-fueled innovations make inroads into agri sector Read More
India accelerates towards Mission 500GW by 2030 Read More
India pitches for increased Japanese investment in emerging sectors Read More
Applications for PLI scheme for white goods reopened Read More
5G introduction to enable a surge in demand for semiconductor chips Read More
India’s exports increase by 33% Read More

News

India’s bio-economy grows to US$ 80 billion in eight years: PM

June 10, 2022

India to get its first drone corridor for taking medical supplies

June 7, 2022

India fastest growing economy among G-20 nations: PM

May 27, 2022

Cowin has administered over 190 crore doses in India

May 10, 2022

M&A activity at  four-year high of US$ 30.3 billion: Report

April 5, 2022
View All